This article is more than 5 years old. Information may no longer be current.
DePuy Synthes enters co-marketing agreement with JointPoint Inc
Click Here to Manage Email Alerts
DePuy Synthes announced an exclusive U.S. agreement with JointPoint Inc. to co-market its proprietary software platform which provides non-invasive computer navigation, pre-surgical digital templating, case planning and feedback during total hip replacement surgeries.
By providing pre-surgical digital templating and real-time, data-driven surgical decision-making in the OR, the easy-to-use, surgeon-friendly navigation system may help reduce leg length discrepancy and complications related to inaccurate cup placement and final implant selection, according to a company press release. The release noted the JointPoint software includes OneTrial, which can predict optimal implant combinations based on pre-surgical goals using two images during surgery. OneTrial also provides precise recommendations on implant size and position for DePuy Synthes implants to enable more confident adjustments and to reduce OR time and fluoroscopy by eliminating re-trialing.
“We are thrilled to partner with JointPoint to help provide more predictive outcomes for surgeons and their patients,” Aaron Villaruz, global hip platform leader of DePuy Synthes Joint Reconstruction, said in the release. “By providing access to important information at key stages of the hip replacement process, together we can help surgeons streamline cases and allow for pre-surgical goals to be achieved more consistently.”
Reference: